Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-Analysis

BackgroundThe pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected all age groups, including the pediatric population, in 3–5% of all cases. We performed a meta-analysis to understand the survival and associated complications in pediatric cancer pati...

Full description

Bibliographic Details
Main Authors: Elisa Dorantes-Acosta, Diana Ávila-Montiel, Miguel Klünder-Klünder, Luis Juárez-Villegas, Horacio Márquez-González
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.608282/full
_version_ 1818732272993435648
author Elisa Dorantes-Acosta
Diana Ávila-Montiel
Miguel Klünder-Klünder
Luis Juárez-Villegas
Horacio Márquez-González
Horacio Márquez-González
author_facet Elisa Dorantes-Acosta
Diana Ávila-Montiel
Miguel Klünder-Klünder
Luis Juárez-Villegas
Horacio Márquez-González
Horacio Márquez-González
author_sort Elisa Dorantes-Acosta
collection DOAJ
description BackgroundThe pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected all age groups, including the pediatric population, in 3–5% of all cases. We performed a meta-analysis to understand the survival and associated complications in pediatric cancer patients as well as their hospitalization, intensive care, and ventilation care (supplemental oxygen/endotracheal intubation) needs.MethodsA systematic search was performed using MEDLINE, TRIP Database, International Clinical Trials Registry Platform (WHO), The Cochrane Library, Wiley, LILACS, and Google Scholar. Additionally, a search using the snowball method was performed in Nature, New England Journal of Medicine, Science, JAMA, ELSEVIER editorial, Oxford University Press, The Lancet, and MedRxiv. Searches were conducted until July 18, 2020. A total of 191 cancer patients with coronavirus disease 2019 (COVID-19) were integrated from 15 eligible studies. In a sub-analysis, patients were stratified into two groups: hematological cancer and solid tumors. Outcome measures were overall survival, risk of hospitalized or needing intensive care, and need for ventilatory support in any modality. The random effects statistical analysis was performed with Cochran’s chi square test. The odds ratio (OR) and heterogeneity were calculated using the I2 test.ResultsThe overall survival was 99.4%. There were no statistically significant differences in the risk of hospitalization between hematological malignancies and solid tumors (95% confidence interval [CI] 0.48–18.3; OR = 2.94). The risk of being admitted to the intensive care unit was also not different between hematological malignancies and other tumors (95% CI 0.35–5.81; OR = 1.42). No differences were found for the need of ventilatory support (95% CI 0.14–3.35; OR = 0.68). Although all the studies were cross-sectional, the mortality of these patients was 0.6% at the time of analysis.ConclusionsIn the analyzed literature, survival in the studied group of patients with COVID-19 was very high. Suffering from hematological neoplasia or other solid tumors and COVID-19 was not a risk factor in children with cancer for the analyzed outcomes.
first_indexed 2024-12-17T23:30:57Z
format Article
id doaj.art-69eb25eec4354893b6b88f43ce04a9ed
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-17T23:30:57Z
publishDate 2021-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-69eb25eec4354893b6b88f43ce04a9ed2022-12-21T21:28:39ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-01-011010.3389/fonc.2020.608282608282Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-AnalysisElisa Dorantes-Acosta0Diana Ávila-Montiel1Miguel Klünder-Klünder2Luis Juárez-Villegas3Horacio Márquez-González4Horacio Márquez-González5Biobanco de Investigación en Células Leucémicas, Hospital Infantil de México Federico Gómez, México City, MexicoSubdirección de Investigación, Hospital Infantil de México Federico Gómez, México City, MexicoSubdirección de Investigación, Hospital Infantil de México Federico Gómez, México City, MexicoDepartamento de Onco-Hematología, Hospital Infantil de México Federico Gómez, México City, MexicoInvestigación Clínica, Hospital Infantil de México Federico Gómez, México City, MexicoCardiopatías Congénitas. Hospital de Cardiología, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), México City, MexicoBackgroundThe pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected all age groups, including the pediatric population, in 3–5% of all cases. We performed a meta-analysis to understand the survival and associated complications in pediatric cancer patients as well as their hospitalization, intensive care, and ventilation care (supplemental oxygen/endotracheal intubation) needs.MethodsA systematic search was performed using MEDLINE, TRIP Database, International Clinical Trials Registry Platform (WHO), The Cochrane Library, Wiley, LILACS, and Google Scholar. Additionally, a search using the snowball method was performed in Nature, New England Journal of Medicine, Science, JAMA, ELSEVIER editorial, Oxford University Press, The Lancet, and MedRxiv. Searches were conducted until July 18, 2020. A total of 191 cancer patients with coronavirus disease 2019 (COVID-19) were integrated from 15 eligible studies. In a sub-analysis, patients were stratified into two groups: hematological cancer and solid tumors. Outcome measures were overall survival, risk of hospitalized or needing intensive care, and need for ventilatory support in any modality. The random effects statistical analysis was performed with Cochran’s chi square test. The odds ratio (OR) and heterogeneity were calculated using the I2 test.ResultsThe overall survival was 99.4%. There were no statistically significant differences in the risk of hospitalization between hematological malignancies and solid tumors (95% confidence interval [CI] 0.48–18.3; OR = 2.94). The risk of being admitted to the intensive care unit was also not different between hematological malignancies and other tumors (95% CI 0.35–5.81; OR = 1.42). No differences were found for the need of ventilatory support (95% CI 0.14–3.35; OR = 0.68). Although all the studies were cross-sectional, the mortality of these patients was 0.6% at the time of analysis.ConclusionsIn the analyzed literature, survival in the studied group of patients with COVID-19 was very high. Suffering from hematological neoplasia or other solid tumors and COVID-19 was not a risk factor in children with cancer for the analyzed outcomes.https://www.frontiersin.org/articles/10.3389/fonc.2020.608282/fullsevere acute respiratory syndrome coronavirus 2coronavirus disease 2019childhood cancermeta-analysissystematic reviewmortality
spellingShingle Elisa Dorantes-Acosta
Diana Ávila-Montiel
Miguel Klünder-Klünder
Luis Juárez-Villegas
Horacio Márquez-González
Horacio Márquez-González
Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-Analysis
Frontiers in Oncology
severe acute respiratory syndrome coronavirus 2
coronavirus disease 2019
childhood cancer
meta-analysis
systematic review
mortality
title Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-Analysis
title_full Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-Analysis
title_fullStr Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-Analysis
title_full_unstemmed Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-Analysis
title_short Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-Analysis
title_sort survival and complications in pediatric patients with cancer and covid 19 a meta analysis
topic severe acute respiratory syndrome coronavirus 2
coronavirus disease 2019
childhood cancer
meta-analysis
systematic review
mortality
url https://www.frontiersin.org/articles/10.3389/fonc.2020.608282/full
work_keys_str_mv AT elisadorantesacosta survivalandcomplicationsinpediatricpatientswithcancerandcovid19ametaanalysis
AT dianaavilamontiel survivalandcomplicationsinpediatricpatientswithcancerandcovid19ametaanalysis
AT miguelklunderklunder survivalandcomplicationsinpediatricpatientswithcancerandcovid19ametaanalysis
AT luisjuarezvillegas survivalandcomplicationsinpediatricpatientswithcancerandcovid19ametaanalysis
AT horaciomarquezgonzalez survivalandcomplicationsinpediatricpatientswithcancerandcovid19ametaanalysis
AT horaciomarquezgonzalez survivalandcomplicationsinpediatricpatientswithcancerandcovid19ametaanalysis